CNBG’s mRNA vaccine industrial base breaks ground in Shanghai - (Global Times via NewsPoints Desk)

  • The China National Biotec Group (CNBG) broke ground on an mRNA vaccine industrial base in Shanghai, Global Times reported.

  • The vaccine base of the Virogin-CNBG Joint Venture covers 32,500 square meters, with the production workshop accounting for half the area.

  • Virogin Biotech is a Vancouver-based developer of next-generation oncolytic virus therapeutics.

To read more NewsPoints articles, click here.